2017 annual financial data
ProQR Therapeutics 2017 Operating margin
ProQR Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was 2,648.66%.
Operating income was -40,498,000 EUR and net income was -43,637,000 EUR.
Operating cash flow was -34,951,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -1,529,000 EUR
- Operating income
- -40,498,000 EUR
- Net income
- -43,637,000 EUR
- Operating cash flow
- -34,951,000 EUR